Icecure Medical is trading 7% up at $3.35 as investors extend a rebound that began on August 4 following a recent pullback.
- The stock is moving in tandem with a broader risk-on rally in U.S. equities and notable strength across the healthcare sector.
- No new company-specific news has emerged, with the price action driven primarily by improving market sentiment toward higher-risk names.